Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors.
D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine / Q000494:pharmacology; D000081:Acetamides / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism; D006213:Hallucinogens / Q000494:pharmacology*; D006614:Hindlimb; D006651:Histocytochemistry; D008297:Male; D008635:Mescaline / Q000494:pharmacology; D008995:Monoamine Oxidase / Q000378:metabolism; D009411:Nerve Endings / Q000201:enzymology; D010627:Phenethylamines / Q000494:pharmacology*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism*; D013116:Spinal Cord / Q000378:metabolism
D000081:Acetamides; D006213:Hallucinogens; D010627:Phenethylamines; D011955:Receptors, Drug; D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine; D012701:Serotonin; D008995:Monoamine Oxidase; D008635:Mescaline